Balboa Nephrology Medical Group | San Diego Metro, CA

Research site
8010 Frost Street, San Diego, California, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


1 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis (DUET)

This study will investigate whether RE-021 (Sparsentan), a selective dual-acting receptor antagonist with affinity for endothelin (A type) and angiot...

Active, not recruiting
Focal Segmental Glomerulosclerosis
Drug: Irbesartan
Drug: RE-021 (Sparsentan)

Trial conditions

Chronic Renal Insufficie... (1 trial)
Focal Segmental Glomerul... (1 trial)
Kidney Diseases (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems